Inventor · disambiguated record
John F. Debernardis
Also filed as: DEBERNARDIS JOHN · DEBERNARDIS JOHN F · DEBERNARDIS JOHN FRANCIS
35 granted patents·7 pending applications·696 citations·filing 1980–2011
98Inventor score
Files withABBOTT LAB25MOLECULAR GERIATRICS CORP11APPLIED NEUROSOLOUTIONS1APPLIED NEUROSOLUTIONS FORMALL1DEBERNARDIS JOHN F1
Top patents by PatentIndex Score
42 records- 0196US4634705AAdrenergic amidinesABBOTT LAB·Filed 1986·Granted Jan 6, 1987·78 cites·15 claims
- 0294US5326776AAngiotensin II receptor antagonistsABBOTT LAB·Filed 1993·Granted Jul 5, 1994·92 cites·26 claims
- 0393US5250548AAngiotensin II receptor antagonistsABBOTT LAB·Filed 1992·Granted Oct 5, 1993·57 cites·16 claims
- 0493US5049564A5-HT selective agentsABBOTT LAB·Filed 1989·Granted Sep 17, 1991·42 cites·7 claims
- 0592US4500543ASubstituted 1-aminomethyl-phthalansABBOTT LAB·Filed 1982·Granted Feb 19, 1985·27 cites·7 claims
- 0690US4618683ATetrahydro-6,7-dimethoxy-1H-benz[e]isoinodolines useful in the treatment of hypertension and as sedativesABBOTT LAB·Filed 1984·Granted Oct 21, 1986·24 cites·17 claims
- 0789US4665095AUse of 2-[(3,5-dihalo-4-aminobenzyl)]imidazolines to stimulate alpha-1 adrenergic receptors and to treat nasal congestionABBOTT LAB·Filed 1985·Granted May 12, 1987·50 cites·4 claims
- 0887US4963568ADopamine agonistsABBOTT LAB·Filed 1989·Granted Oct 16, 1990·52 cites·8 claims
- 0984US5244888A5-HT selective agentsABBOTT LAB·Filed 1991·Granted Sep 14, 1993·26 cites·7 claims
- 1083US6864062B2Purified antigen for Alzheimer's disease and methods of obtaining and using sameMOLECULAR GERIATRICS CORP·Filed 2001·Granted Mar 8, 2005·22 cites·5 claims
- 1182US4622405A1,2,3,3a,8,8a-hexahydro-indeno[1,2-c]pyrroles useful in the treatment of hypertensionABBOTT LAB·Filed 1985·Granted Nov 11, 1986·16 cites·3 claims
- 1281US6214994B1Certain substituted 1-aryl-3-piperazin-1′-yl propanonesMOLECULAR GERIATRICS CORP·Filed 1999·Granted Apr 10, 2001·22 cites·3 claims
- 1381US4473586AAminoalkyl dihydronaphthalenesABBOTT LAB·Filed 1982·Granted Sep 25, 1984·13 cites·9 claims
- 1476US5693804ASubstituted 1-aryl-3-piperazin-1'-yl propanonesMOLECULAR GERIATRICS CORP·Filed 1994·Granted Dec 2, 1997·17 cites·11 claims
- 1575US4440769A2-(4-Phenylalkanoylpiperazin-1-yl) quinazoline compounds, pharmaceutical compositions and method of producing α1 antagonistic activityABBOTT LAB·Filed 1983·Granted Apr 3, 1984·8 cites·16 claims
- 1674US5140040A1-aminomethyl-1,2,3,4-tetrahydronaphthalenesABBOTT LAB·Filed 1991·Granted Aug 18, 1992·13 cites·5 claims
- 1772US5128362A1-aminomethyl-1,2,3,4-tetrahydronaphthalenesABBOTT LAB·Filed 1990·Granted Jul 7, 1992·12 cites·16 claims
- 1871US5288749ATertiary and secondary amines as alpha-2 antagonists and serotonin uptake inhibitorsABBOTT LAB·Filed 1991·Granted Feb 22, 1994·26 cites·13 claims
- 1971US4963563A6-substituted-1,2,3,4-tetrahydroisoquinolinesABBOTT LAB·Filed 1989·Granted Oct 16, 1990·15 cites·7 claims
- 2069US4505932AMethod of producing α2 -adrenergic receptor agonist activityABBOTT LAB·Filed 1984·Granted Mar 19, 1985·8 cites·6 claims
- 2168US5185364AAminomethyl-chroman and -thiochroman compoundsABBOTT LAB·Filed 1991·Granted Feb 9, 1993·10 cites·6 claims
- 2264US2008181883A1Purified Antigen for Alzheimer's Disease and Methods of Obtaining and Using SameAPPLIED NEUROSOLUTIONS FORMALL·Filed 2008·Application pending·0 cites
- 2363US5658909ACertain substituted 1-aryl-3-piperazin-1'-yl propanones to treat Alzheimer's DiseaseMOLECULAR GERIATRICS CORP·Filed 1994·Granted Aug 19, 1997·23 cites·5 claims
- 2462US5140039AAminomethyl-thiochroman compoundsABBOTT LAB·Filed 1991·Granted Aug 18, 1992·7 cites·7 claims
- 2561US5389638ATetrahydroisoquinolines as alpha-2 antagonists and biogenic amine uptake inhibitorsABBOTT LAB·Filed 1993·Granted Feb 14, 1995·7 cites·10 claims
- 2659US5705501ACertain substituted 1-aryl-3-morpholinopropanones to treat Alzheimer's DiseaseMOLECULAR GERIATRICS CORP·Filed 1994·Granted Jan 6, 1998·18 cites·6 claims
- 2751US7173132B2Certain substituted 1-aryl-3-piperazine-1′-yl propanonesMOLECULAR GERIATRICS CORP·Filed 2002·Granted Feb 6, 2007·0 cites·2 claims
- 2850US2009022825A1Method for Predicting Whether Subjects With Mild Cognitive Impairment (MCI) Will Develop Alzheimer's DiseaseAPPLIED NEUROSOLOUTIONS·Filed 2008·Application pending·0 cites
- 2950US2005272094A1Purified antigen for Alzheimer's disease and methods of obtaining and using sameMOLECULAR GERIATRICS CORP·Filed 2005·Application pending·0 cites
- 3048US2004166536A1Method for predicting whether subjects with mild cognitive impairment (MCI) will develop Alzheimer's DiseaseMOLECULAR GERIATRICS CORP·Filed 2003·Application pending·0 cites
- 3147US5086074A1-aminomethyl-1,2,3,4-tetrahydronaphthalenesABBOTT LAB·Filed 1990·Granted Feb 4, 1992·3 cites·5 claims
- 3246US2001025105A1Certain substituted 1-aryl-3-piperazine-1'-yl propanonesMOLECULAR GERIATARICS CORP·Filed 2001·Application pending·0 cites
- 3342US5180733ABiogenic amine uptake inhibitorsABBOTT LAB·Filed 1991·Granted Jan 19, 1993·4 cites·9 claims
- 3440US2013095492A1Method of detecting tau protein and tau fragments in serumDEBERNARDIS JOHN F·Filed 2011·Application pending·0 cites
- 3539US5248677ABiogentic amine uptake inhibitorsABBOTT LAB·Filed 1992·Granted Sep 28, 1993·1 cites·10 claims
- 3635US6075026ACertain substituted 1-aryl-3-piperazin-1'-yl propanonesMOLECULAR GERIATRICS CORP·Filed 1997·Granted Jun 13, 2000·1 cites·1 claims
- 3733US5089519AAminomethyl-chroman compoundsABBOTT LAB·Filed 1989·Granted Feb 18, 1992·0 cites·7 claims
- 3832US6228878B1Methods for treating or preventing alzheimer's disease using substituted 2-aryl-3-morpholinopropanonesMOLECULAR GERIATRICS CORP·Filed 1999·Granted May 8, 2001·0 cites·2 claims
- 3931US6306857B1Methods for treating or preventing alzheimer's disease using substituted 1-aryl-3-piperazin-1′-yl propanonesMOLECULAR GERIATRICS CORP·Filed 1999·Granted Oct 23, 2001·0 cites·24 claims
- 4031US5968936AMethods for treating or preventing Alzheimer's Disease using substituted 1-aryl-3-morpholinopropanonesMOLECUALR GERIATRICS CORP·Filed 1997·Granted Oct 19, 1999·2 cites·2 claims
- 4130US2002002270A1Purified antigen for alzheimer's disease, and methods of obtaining and using sameFiled 1999·Application pending·0 cites
- 4229US4269858AAntihypertensive methodABBOTT LAB·Filed 1980·Granted May 26, 1981·0 cites·6 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →